EPAS1 Antikörper (N-Term)
-
- Target Alle EPAS1 Antikörper anzeigen
- EPAS1 (Endothelial PAS Domain Protein 1 (EPAS1))
-
Bindungsspezifität
- AA 127-154, N-Term
-
Reaktivität
- Human
-
Wirt
- Kaninchen
-
Klonalität
- Polyklonal
-
Konjugat
- Dieser EPAS1 Antikörper ist unkonjugiert
-
Applikation
- Western Blotting (WB), ELISA, Flow Cytometry (FACS)
- Kreuzreaktivität
- Human
- Kreuzreaktivität (Details)
- Calculated cross reactivity: Hu
- Produktmerkmale
- EPAS1, NT (EPAS1, BHLHE73, HIF2A, MOP2, PASD2, Endothelial PAS domain-containing protein 1, Basic-helix-loop-helix-PAS protein MOP2, Class E basic helix-loop-helix protein 73, HIF-1-alpha-like factor, Hypoxia-inducible factor 2-alpha, Member of PAS protein 2, PAS domain-containing protein 2)
- Aufreinigung
- Purified by Protein A affinity chromatography.
- Immunogen
- EPAS1 antibody is generated from rabbits immunized with a KLH conjugated synthetic peptide between 127-154 amino acids from the N-terminal region of human EPAS1.
- Isotyp
- IgG
- Top Product
- Discover our top product EPAS1 Primärantikörper
-
-
- Applikationshinweise
- Optimal working conditions should be determined by the investigator.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Liquid
- Buffer
- Supplied as a liquid in PBS, pH 7.2, 0.09 % sodium azide.
- Konservierungsmittel
- Sodium azide
- Vorsichtsmaßnahmen
- This product contains Sodium azide: a POISONOUS AND HAZARDOUS SUBSTANCE which should be handled by trained staff only.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- -20°C
-
- Target
- EPAS1 (Endothelial PAS Domain Protein 1 (EPAS1))
- Andere Bezeichnung
- EPAS1 (EPAS1 Produkte)
- NCBI Accession
- NP_001421
- UniProt
- Q99814
- Pathways
- Signaling Events mediated by VEGFR1 and VEGFR2, Warburg Effekt
-